Dr. Abdelouahid Samadi is an Associate Professor of Medicinal Chemistry at the United Arab Emirates University. He collaborates with prestigious institutions. Among them are the Institute of Organic Chemistry, CSIC, Spain, and the Faculty of Sciences, Ben M'Sick University, Casablanca, Morocco. Dr. Samadi is a well-known Medicinal Chemist. He contributed to innovative research on Alzheimer's and Parkinson’s diseases. One of his major contributions to the field of medicinal chemistry is the development of the molecule ASS234, a multitarget derivative designed to treat Alzheimer's disease. Dr. Samadi has over 20 years of experience in medicinal chemistry and has published more than 110 peer-reviewed articles, two book chapters, and several international patents. His work has received significant international recognition, with more than 3,996 citations across 2,892 documents and an h-index of 34. He currently leads a research group involving design, synthesis, spectroscopic characterization, biological evaluation, docking studies, and metal chelation.